Source:http://linkedlifedata.com/resource/pubmed/id/21499025
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-4-18
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
2150-5608
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
86-90
|
pubmed:meshHeading |
pubmed-meshheading:21499025-Acinetobacter Infections,
pubmed-meshheading:21499025-Acinetobacter baumannii,
pubmed-meshheading:21499025-Anti-Bacterial Agents,
pubmed-meshheading:21499025-Cross Infection,
pubmed-meshheading:21499025-Drug Resistance, Multiple, Bacterial,
pubmed-meshheading:21499025-Humans
|
pubmed:articleTitle |
Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.
|
pubmed:publicationType |
Editorial,
Comment,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, N.I.H., Extramural
|